GATA2 NM_032638.5(GATA2):c.1034_1035insTCTTCTTGTGGCGGCTCTTCTGGCGGC (p.Ala345_Gly346insLeuLeuValAlaAlaLeuLeuAlaAla) — variant · CancerIndex

Variant · Other

GATA2 NM_032638.5(GATA2):c.1034_1035insTCTTCTTGTGGCGGCTCTTCTGGCGGC (p.Ala345_Gly346insLeuLeuValAlaAlaLeuLeuAlaAla)

CI-VAR-00197381Explore in graph →p.Ala345_Gly346insLeuLeuValAlaAlaLeuLeuAlaAlaNM_032638.5:c.1034_1035insTCTTCTTGTGGCGGCTCTTCTGGCGGCClinVar 1184020 rs2107668794

Curated evidence

Evidence by cancer (0 items)

Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.

Data not yet available

No curated evidence item references this variant yet.

ClinVar

Clinical significance (1)

ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.

clinvarCurated1 interpretation · review status and star rating as assigned by ClinVar.

Variation	Clinical significance	Review status	Stars	Conditions	Origin	Submitters	Last evaluated	Source
1184020	Likely pathogenic	criteria provided, single submitter	1	Deafness-lymphedema-leukemia syndrome; GATA2 deficiency with susceptibility to MDS/AML	germline	1	Jul 06, 2021	clinvar